Welcome to the Novartis Diagnostics Newsroom. If you are a journalist or with the media and would like to inquire about Novartis or one of its companies, please contact Diagnostics Communications

Sophia Daryanani-Patel
510-923-3365

 

Novartis Receives Excellence in Community Service Award from the American Red Cross
June 14, 2007 - What do a big giant blood drop, romance movies and a phone bank have in common? These are some of the unique and creative ways Novartis Vaccines and Diagnostics, Inc. in Emeryville encourages and promotes blood drives within their organization.
more »

 

Novartis Receives Health Canada Approval for First Fully Automated Nucleic Acid Testing Solution to Screen for West Nile Virus

May 15, 2007 - Novartis announced today that Health Canada has approved the PROCLEIX® West Nile Virus (WNV) Assay and the PROCLEIX® TIGRIS® System, the first fully automated Nucleic Acid Testing (NAT) solution to screen for the West Nile virus
more»

 

Novartis to market newly approved PROCLEIX® TIGRIS® System in U.S. as the first fully automated system for West Nile virus blood screening
March 2, 2007 - Novartis announced today that the U.S. Food and Drug Administration (FDA) has cleared the PROCLEIX® TIGRIS® System, the first fully automated nucleic acid testing system, to screen donated blood, organs and tissue for the West Nile virus
more»

 

Novartis and American Red Cross Blood Services sign long-term supply agreement for Nucleic Acid Testing products
June 27, 2006 - Multi-year agreement provides American Red Cross with access to state-of-the-art technology to ensure safety of the US blood supply and prevent spread of diseases
more »